Passive Stretching Versus Electrical Stimulation on Glucose Level, in Elderly With Type II Diabetes
NCT ID: NCT06245252
Last Updated: 2024-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-02-10
2024-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxidative Stress in Response to Electroacupuncture Against Physical Activity in Diabetic Patients
NCT04643171
Effect of Neurodynamic Mobilization Techniques in Patients With Diabetic Neuropathy
NCT05628168
Home-based Proprioceptive Neuromuscular Facilitation for Subjects With Type 2 Diabetes Mellitus
NCT03248206
Effect of Foot Muscle Energy Technique in Patients With Diabetic Neuropathy
NCT05790421
Surface Electromyography Study of Fatigue in Diabetic Neuropathy
NCT04467255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group (A)
treated by 40-minute passive stretching exercises,three times per week for 12 weeks
passive stretching for group A
A description of stretch is performed 3 times per week for 12 weeks. The stretches included (in the order they were applied): Seated knee flexor (bilateral); Seated knee flexor-hip adductor (bilateral); Seated shoulder lateral flexor (bilateral); Supine hip flexor- knee extensor (unilateral). Seated hip external rotators, extensor (unilateral); Seated shoulder extensors, adductors, retractors (unilateral). Supine knee flexor-plantar flexor (unilateral); Prone hip flexor (unilateral); Seated shoulder flexors, depressors (bilateral); Seated shoulder and elbow flexors (unilateral).
group (B)
treated by 30 minutes electrical stimulation three times per week for 12 weeks
electrical stimulation for group b
reated by 30 minutes electrical stimulation three times per week for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
passive stretching for group A
A description of stretch is performed 3 times per week for 12 weeks. The stretches included (in the order they were applied): Seated knee flexor (bilateral); Seated knee flexor-hip adductor (bilateral); Seated shoulder lateral flexor (bilateral); Supine hip flexor- knee extensor (unilateral). Seated hip external rotators, extensor (unilateral); Seated shoulder extensors, adductors, retractors (unilateral). Supine knee flexor-plantar flexor (unilateral); Prone hip flexor (unilateral); Seated shoulder flexors, depressors (bilateral); Seated shoulder and elbow flexors (unilateral).
electrical stimulation for group b
reated by 30 minutes electrical stimulation three times per week for 12 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ranged from 60-75 years patients have
* body mass index (BMI) from 25 to 29.9 kg/m2,
* duration of diabetes ranged from 5-7 years. They were
* on oral hypoglycemic medications at the same dose.
* All patients were clinically and medically stable when attending the study.
Exclusion Criteria
* chest problems
* other types of diabetes
* on insulin therapy
* chronic renal failure and
* iron deficient anemia and
* musculoskeletal disorders which may affect their physical ability to do the exercises.
60 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mona Mohamed Abdelkhalek
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mona Mohamed Abdelkhalek
assistance professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Badr university
Cairo, , Egypt
Mona Mohamed Abdelkhalek
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mona Abdelkhalek, Phd
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mona 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.